![Chemical structure of Phenol, 2-methoxy-5-[(1Z)-2-(3,4,5-trimethoxyphenyl)ethenyl]-, CAS 117048-59-6](https://api.angenesci.com/structure/1300/117048-59-6.png)
无数据
无数据
无数据
| CAS Number | 117048-59-6 |
| Catalog Number | AG000DMO(AGN-PC-0NZ6CE) |
| Chemical Name | Phenol, 2-methoxy-5-[(1Z)-2-(3,4,5-trimethoxyphenyl)ethenyl]- |
| IUPAC Name | 2-methoxy-5-[(Z)-2-(3,4,5-trimethoxyphenyl)ethenyl]phenol |
| InChI | InChI=1S/C18H20O5/c1-20-15-8-7-12(9-14(15)19)5-6-13-10-16(21-2)18(23-4)17(11-13)22-3/h5-11,19H,1-4H3/b6-5- |
| InChI Key | HVXBOLULGPECHP-WAYWQWQTSA-N |
| MDL Number | MFCD03453309 |
| Molecular Formula | C18H20O5 |
| Molecular Weight | 316.3484 |
| NSC Number | 613729 |
| SMILES | O(C)C1=C(OC)C=C(/C=C\C2=CC(O)=C(OC)C=C2)C=C1OC |
| UNII | 16U6OP69RQ |
| Synonyms | 1-(3,4,5-trimethoxyphenyl)-2-(3'-hydroxy-4'-methoxyphenyl)ethene,
2-methoxy-5-((z)-2-(3,4,5-trimethoxyphenyl)vinyl)phenyl dihydrogen phosphate,
3,4,5-trimethoxy-3'-hydroxy-4'-methoxystilbene,
CA4DP,
combretastatin A-4,
combretastatin A-4 disodium phosphate,
combretastatin A4,
combretastatin A4 phosphate,
CRC 87-09,
CRC-98-09,
deoxycombretastatin A-4,
fosbretabulin,
isocombretastatin A-4,
NSC 817373,
NSC-817373,
phenol, 2-methoxy-5-((1z)-2-(3,4,5-trimethoxyphenyl)ethenyl)-,1-(dihydrogen phosphate),
phenol, 2-methoxy-5-((z)-2-(3,4,5-trimethoxyphenyl)ethenyl)-, dihydrogen phosphate,
Combretastatin A4,
117048-59-6,
Combretastatin A-4,
Combretastatin-A4,
Crc 87-09,
UNII-16U6OP69RQ,
NSC 817373,
Combrestatin A4,
(Z)-2-METHOXY-5-(3,4,5-TRIMETHOXYSTYRYL)PHENOL,
CHEMBL67,
NSC-613729,
16U6OP69RQ,
HVXBOLULGPECHP-WAYWQWQTSA-N,
MFCD03453309,
CA-4,
Crc-98-09,
2-methoxy-5-[(Z)-2-(3,4,5-trimethoxyphenyl)ethenyl]phenol,
3,4,5-Trimethoxy-3'-hydroxy-4'-methoxystilbene,
2-Methoxy-5-[(1Z)-2-(3,4,5-trimethoxyphenyl)ethenyl]phenol,
2-Methoxy-5-[(Z)-2-(3,4,5-trimethoxy-phenyl)-vinyl]-phenol,
NSC 609397,
NSC 613729,
1-(3,4,5-Trimethoxyphenyl)-2-(3'-hydroxy-4'-methoxyphenyl)ethene,
Phenol, 2-methoxy-5-(2-(3,4,5-trimethoxyphenyl)ethenyl)-, (Z)-,
Phenol, 2-methoxy-5-[2-(3,4,5-trimethoxyphenyl)ethenyl]-, (Z)-,
combretastin A4,
Combrestatin A-4,
Combretastin A-4,
AK128410,
CA4,
Combretastastin A-4,
2-methoxy-5-(3,4,5-trimethoxystyryl)phenol,
Z-Combretastatin A-4,
AC1NS0CC,
2-methoxy-5-[2-(3,4,5-trimethoxyphenyl)ethenyl]phenol,
2-Methoxy-5-[2-(3,4,5-trimethoxy-phenyl)-vinyl]-phenol,
CS-A4,
SCHEMBL18945,
combretastatin A-4, (CSA4),
Phenol, 2-methoxy-5-[(1Z)-2-(3,4,5-trimethoxyphenyl)ethenyl]-,
CA 4,
GTPL8854,
PHE021,
AOB1953,
HMS3650G11,
ACT02766,
HY-N2146,
BDBM50005480,
BG0511,
s7783,
ZINC13452167,
AKOS015950727,
AC-5280,
ACN-028881,
CS-6023,
DS-5860,
MCULE-9118029221,
Phenol,4,5-trimethoxyphenyl)ethenyl]-,
RL00638,
ST-1986,
AJ-63828,
BC226031,
SC-96865,
AB0073032,
AB1003973,
AX8017677,
ST2401963,
ST4149439,
TL8000482,
B6764,
Combretastatin A4, >=98% (HPLC), powder,
Y0443,
5-(3,4,5-trimethoxystyryl)-2-methoxyphenol,
A12601,
C20268,
3'-Hydroxy-3,4,4',5-tetramethoxy-cis-stilbene,
(Z)-5-(3,4,5-trimethoxystyryl)-2-methoxyphenol,
048C596,
SR-01000946784,
(Z)-3''-hydroxy-3,4,4'',5-tetramethoxystilbene,
SR-01000946784-1,
[3,4,5-trimethoxy-3'-hydroxy-4'-methoxy-(z)-stilbene],
2-methoxy-5-[(Z)-2-(3,4,5-trimethoxyphenyl)vinyl]phenol,
2-methoxy-5-[(1Z)-2-(3,4,5-trimethoxyphenyl)ethenyl]-phenol,
5-[(1Z)-2-(3,4,5-trimethoxyphenyl)vinyl]-2-methoxyphenol,
2-Methoxy-5-[(Z)-2-(3,4,5-trimethox y-phenyl)-vinyl]-phenol,
2-methoxy-5-[(Z)-2-(3,4,5-trimethoxyphenyl)-1-ethenyl]phenol,
(combretastin A-4)2-Methoxy-5-[2-(3,4,5-trimethoxy-phenyl)-vinyl]-phenol,
(combretastatin A-4)2-Methoxy-5-[2-(3,4,5-trimethoxy-phenyl)-vinyl]-phenol,
(Z)-2-Methoxy-5-[2-(3,4,5-trimethoxyphenyl)ethenyl]phenol, 3,4,5-Trimethoxy-3 inverted exclamation mark -hydroxy-4 inverted exclamation mark -methoxy-(Z)-stilbene,
1-(3,4,5-Trimethoxyphenyl)-2-(3'-hydroxy-4'-methoxyphenyl) ethane 3,4,5-trimethoxy-3'-hydroxy-4'-methoxystilbene,
2-Methoxy-5-[(1Z)-2-(3,4,5-trimethoxyphenyl)ethenyl]phenol; CA4; 1-(3,4,5-Trimethoxyphenyl)-2-(3 inverted exclamation marka-hydroxy-4 inverted exclamation marka-methoxyphenyl) ethane 3,4,5-trimethoxy-3 inverted exclamation marka-hydroxy-4 inverted exclamation marka-methoxystilbene,
Combretastatin,
Fosbretabulin,
(-)-Combretastatin,
isocombretastatin A-4,
deoxycombretastatin A-4,
CA4DP,
(Z)-Combretastatin A4,
combretastatin A4 phosphate,
cc-322,
C18H20O5,
NSC613729,
combretastatin A-4 disodium phosphate,
C18-H20-O5,
CID5351344,
NSC-817373,
Combretastatin A-4, 98% - 25MG 25mg,
C2520,
C058728,
5-[(S)-2-Hydroxy-2-(3,4,5-trimethoxy-phenyl)-ethyl]-2-methoxy-phenol,
2-methoxy-5-((z)-2-(3,4,5-trimethoxyphenyl)vinyl)phenyl dihydrogen phosphate,
phenol, 2-methoxy-5-((1z)-2-(3,4,5-trimethoxyphenyl)ethenyl)-,1-(dihydrogen phosphate),
phenol, 2-methoxy-5-((z)-2-(3,4,5-trimethoxyphenyl)ethenyl)-, dihydrogen phosphate,
|
| Complexity | 358 |
| Compound Is Canonicalized | Yes |
| Covalently-Bonded Unit Count | 1 |
| Defined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 1 |
| Exact Mass | 316.131g/mol |
| Formal Charge | 0 |
| Heavy Atom Count | 23 |
| Hydrogen Bond Acceptor Count | 5 |
| Hydrogen Bond Donor Count | 1 |
| Isotope Atom Count | 0 |
| Molecular Weight | 316.353g/mol |
| Monoisotopic Mass | 316.131g/mol |
| Rotatable Bond Count | 6 |
| Topological Polar Surface Area | 57.2A^2 |
| Undefined Atom Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| XLogP3 | 3.7 |
| Symbol: | |
| Hazard Class | 6.1 |
| Hazard statements | H317-H319 |
| Packing Group | Ⅲ |
| Precautionary statements | P280-P305+P351+P338 |
| UN Code | UN 2811 |
| Chemical Name: | Batch Number: | |
| Chemical Structure: | CAS Registry No: | |
| Product ID: | ||
| Manufacture Date: | ||
| Storage Temperature: | ||
| Formula: | ||
| Molecular Weight: | ||
| Quantity: |
| Test: | Result: |

